Tag: Wegovy
Weight loss drug candidates multiply, spurring hopes of lower costs
New data on weight loss drugs that could compete with Novo Nordisk's Wegovy are raising expectations there will soon be more options, and possibly...
Novo Nordisk invests £1.8 bln in Danish production facility
Hot on the heels of its popularity over weight-loss drug Wegovy, Danish drugmaker Novo Nordisk is to invest £1.8 billion to expand a production...
Weight-loss drugs pilot to begin in UK amid uncertainty over Wegovy launch
Britain plans to launch a pilot programme exploring how new weekly weight-loss shots such as Novo Nordisk's Wegovy can be given to obese patients by general...
Obesity fighting success fuels Novo Nordisk’s bet on gene-editing technology in pharma
Capitalising on strong demand for its obesity therapies, Novo Nordisk's growing appetite for deals has fuelled a bet on a U.S. gene-editing company called...
Weight-loss drug pioneers aim to jump on Novo Nordisk’s Wegovy bandwagon
Weight loss drug Wegovy has transformed the obesity market and pharmaceutical companies with existing treatments are hoping the resulting demand will boost demand for...
Novo Nordisk warns of supply constraints on its best-selling diabetes drug
Danish drug developer Novo Nordisk on Wednesday (February 1) warned of supply constraints on its best-selling drug.
The company, which develops diabetes and obesity drugs,...